Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
6°
Partly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Day One Biopharmaceuticals Inc
(NQ:
DAWN
)
13.72
+0.18 (+1.33%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Day One Biopharmaceuticals Inc
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 25, 2023
Via
Benzinga
Lam Research, D.R. Horton, Las Vegas Sands And Other Big Stocks Moving Higher On Thursday
April 20, 2023
U.S. stocks traded lower, with the Dow Jones dropping around 100 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Day One Announces Upcoming Presentation at 19th European Association of Dermato-Oncology (EADO) Congress
April 12, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Analyst Expectations for Day One Biopharmaceutical's Future
April 05, 2023
Via
Benzinga
What 8 Analyst Ratings Have To Say About Day One Biopharmaceutical
March 07, 2023
Via
Benzinga
Where Day One Biopharmaceutical Stands With Analysts
February 03, 2023
Via
Benzinga
What 7 Analyst Ratings Have To Say About Day One Biopharmaceutical
January 09, 2023
Via
Benzinga
This Pediatric Cancer Company Makes It To Analyst's Conviction List
December 14, 2022
Via
Benzinga
Day One Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Progress
March 06, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Day One to Participate in the Cowen 43rd Annual Health Care Conference
February 27, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
February 16, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023
February 03, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 8, 2023
February 08, 2023
Via
Benzinga
Day One Biopharmaceuticals Shares Jump As Pediatric Brain Cancer Candidate Shows Encouraging Responses
January 09, 2023
Via
Benzinga
Day One Announces Topline Data from Pivotal Phase 2 FIREFLY-1 Trial Demonstrating Meaningful Responses with Tovorafenib (DAY101) in Recurrent or Progressive Pediatric Low-Grade Glioma
January 08, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Day One to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 20, 2022
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For December 5, 2022
December 05, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
December 15, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
December 01, 2022
Via
Benzinga
Day One to Participate in the Piper Sandler 34th Annual Healthcare Conference
November 17, 2022
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Day One Announces Upcoming Presentations at 2022 Society for Neuro-Oncology Annual Meeting
November 11, 2022
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Day One Reports Third Quarter 2022 Financial Results and Corporate Progress
November 07, 2022
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Day One Announces Cooperative Research and Development Agreement with National Cancer Institute to Expand Development of Tovorafenib (DAY101)
October 17, 2022
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Central Nervous System Disorders Therapeutics Market Expected to Reach $159 Billion by 2028
October 12, 2022
Palm Beach, FL –– October 12, 2022 – FinancialNewsMedia.com News Commentary – The COVID pandemic has not only had a negative effect on most markets but it has also spurred growth in several worldwide...
Via
FinancialNewsMedia
Exposures
COVID-19
5 Value Stocks In The Healthcare Sector
August 22, 2022
What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators...
Via
Benzinga
LegalZoom.com, Toast And Some Other Big Stocks Moving Higher On Friday
August 12, 2022
WeTrade Group, Inc. (NASDAQ: WETG) jumped 46% to $20.56 after the company announced it entered into a sales agreement with Parkway Medical Limited to sell monkeypox virus test kits and antigen tests...
Via
Benzinga
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
August 15, 2022
Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.
Via
Benzinga
Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session
August 12, 2022
Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 20, 2022
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares increased by 15.1% to $0.63 during Wednesday's after-market session. The company's market cap stands at $16.7 million.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.